HistCite Tip of the DayX
Tip of the day
 Previous Tip Next Tip Close 
Add FileX ?
Use [Browse...] to select a file with bibliography data:
Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.
4 March 2011
Records: 12830, Authors: 27826, Journals: 1715, Cited References: 269269, Words: 9469
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country
Page 4 of 129: [  1  2  3  4  5  6  7  8  9  10 ]  11   21   31   41   51   61   71   81   91  |  101 
#Date / Author / JournalLCSGCSLCRCR
301234 LARSSON EI
DIGITAL STEREOSCINTIGRAPHIC EXPERIMENTS WITH A GAMMA-CAMERA
ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY. 1972; 11 (2): 135-& 		01513
302335 LARSSON S, LIND M, SODERBORG B
OBJECTIVE SYMMETRY DETECTOR METHOD FOR GAMMA-ENCEPHALOGRAPHY .1. PHYSICAL CHARACTERISTICS
ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY. 1975; 14 (1): 63-80 		07115
303336 THIEME GA, HENDEE WR, IBBOTT GS, CARSON PL, KIRCH DL
CROSS-SECTIONAL ANATOMIC IMAGES BY GAMMA-RAY TRANSMISSION SCANNING
ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY. 1975; 14 (1): 81-112 		19115
30448 KVICALA V
DIAGNOSIS OF BRAIN LESIONS BY MEANS OF RADIOISOTOPES
ACTA UNIVERSITATIS CAROLINAE MEDICA. 1966; (M23): 7-& 		000256
3057632 Doval O, Gaviria M
Frontotemporal dementia
ACTAS ESPANOLAS DE PSIQUIATRIA. 1999 MAR-APR; 27 (2): 111-126 		0014141
3068105 Crespo-Facorro B, Arango C
Schizophrenia: a brain disease. II. Functional neuroimaging
ACTAS ESPANOLAS DE PSIQUIATRIA. 2000 JAN-FEB; 28 (1): 31-39 		012486
3078493 Doval O, Gaviria M
Frontotemporal dementia
ACTAS ESPANOLAS DE PSIQUIATRIA. 2000 DEC; 28 (8): 13-28 		0014142
3085617 GONZALEZTORRECILLAS JL, STANER L, MENDLEWICZ J
CEREBRAL BLOOD-FLOW AND POST-TIA DEPRESSION
ACTAS LUSO-ESPANOLAS DE NEUROLOGIA PSIQUIATRIA Y CIENCIAS AFINES. 1995 MAR-APR; 23 (2): 52-57 		02341
3097759 Abbott NJ, Chugani DC, Zaharchuk G, Rosen BR, Lo EH
Delivery of imaging agents into brain
ADVANCED DRUG DELIVERY REVIEWS. 1999 MAY 4; 37 (1-3): 253-277 		02022153
3107760 Bogdanov AA, Lewin M, Weissleder R
Approaches and agents for imaging the vascular system
ADVANCED DRUG DELIVERY REVIEWS. 1999 MAY 4; 37 (1-3): 279-293 		029396
#Date / Author / JournalLCSGCSLCRCR
3118199 Saleem A, Aboagye EO, Price PM
In vivo monitoring of drugs using radiotracer techniques
ADVANCED DRUG DELIVERY REVIEWS. 2000 MAR 15; 41 (1): 21-39 		21918135
31212715 Li ZB, Conti PS
Radiopharmaceutical chemistry for positron emission tomography
ADVANCED DRUG DELIVERY REVIEWS. 2010 AUG 30; 62 (11): 1031-1051 		0015274
31312716 Wu ZH, Kandeel F
Radionuclide probes for molecular imaging of pancreatic beta-cells
ADVANCED DRUG DELIVERY REVIEWS. 2010 AUG 30; 62 (11): 1125-1138 		0010122
3149122 He HX, Tao NJ
Interactions of molecules with metallic quantum wires
ADVANCED MATERIALS. 2002 JAN 16; 14 (2): 161-+ 		112226
3151429 GREITZ T
POSITRON EMISSION TOMOGRAPHY FOR QUANTITATIVE INVIVO STUDIES OF NEUROTRANSMITTER KINETICS - A CRITICAL-EVALUATION
ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY. 1984; 39: 69-78 		00422
3162458 GOLDMAN H, BERMAN RF, MURPHY S
ACTH-RELATED PEPTIDES, KINDLING AND SEIZURE DISORDERS
ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY. 1987; 43: 317-327 		05373
3173419 TSUCHIYA T
CHEMISTRY AND DEVELOPMENTS OF FLUORINATED CARBOHYDRATES
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY. 1990; 48: 91-277 		2122126870
318273 LONGO LD, HILL EP, POWER GG
FACTORS AFFECTING PLACENTAL OXYGEN TRANSFER
ADVANCES IN CHEMISTRY SERIES. 1973; (118): 88-129 		001352
319787 COOPER AJL, DUFFY TE, MCDONALD JM, GELBARD AS
N-13 AS A TRACER FOR STUDYING AMMONIA UPTAKE AND METABOLISM IN THE BRAIN
ADVANCES IN CHEMISTRY SERIES. 1981; (197): 369-388 		00578
320788 WELCH MJ, WITTMER SL, DENCE CS, TEWSON TJ
RADIOPHARMACEUTICALS LABELED WITH C-11 AND F-18 - CONSIDERATIONS RELATED TO THE PREPARATION OF C-11-LABELED PALMITATE
ADVANCES IN CHEMISTRY SERIES. 1981; (197): 407-417 		04240
#Date / Author / JournalLCSGCSLCRCR
321789 RAICHLE ME
POSITRON EMISSION TOMOGRAPHY TRACER TECHNIQUES
ADVANCES IN CHEMISTRY SERIES. 1981; (197): 420-& 		00841
322790 ROBINSON GD
INVIVO TRACERS FOR STUDIES OF MYOCARDIAL-METABOLISM
ADVANCES IN CHEMISTRY SERIES. 1981; (197): 437-451 		00976
32311666 Sokoloff L
The Physiological and Biochemical Bases of Functional Brain Imaging
ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS. 2008; : 327-334 		00627
3248024 Jellinger KA
Morphological substrates of mental dysfunction in Lewy body disease: an update
ADVANCES IN DEMENTIA RESEARCH. 2000; : 185-212 		0017150
3252459 NATTERER F
ATTENUATION CORRECTION IN EMISSION TOMOGRAPHY
ADVANCES IN ELECTRONICS AND ELECTRON PHYSICS. 1987; : 21-33 		10113
326791 LINDGREN AG, RATTEY PA
THE INVERSE DISCRETE RADON-TRANSFORM WITH APPLICATIONS TO TOMOGRAPHIC IMAGING USING PROJECTION DATA
ADVANCES IN ELECTRONINCS AND ELECTRON PHYSICS. 1981; 56: 359-410 		022677
3271187 GRIEB P, FORSTER RE, PAPE PC
OXYGEN INDICATOR DILUTION CURVES OF THE CANINE CEREBRAL-CIRCULATION
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 1983; 159: 103-117 		02131
3281430 BREULL W, RUBART M
DISTRIBUTION OF MYOCARDIAL GLUCOSE CONSUMPTION UNDER NORMAL CONDITIONS AND DURING ISOPRENALINE AND DOBUTAMINE INFUSION
ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 1984; 169: 369-380 		03321
32910844 Li D, Zuo C, Guan Y, Zhao Y, Shen J, et al.
FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease
ADVANCES IN FUNCTIONAL AND REPARATIVE NEUROSURGERY. 2006; 99: 51-54 		0317
3304621 TESAR GE, ROSENBAUM JF
RECOGNITION AND MANAGEMENT OF PANIC DISORDER
ADVANCES IN INTERNAL MEDICINE, VOLUME 38. 1993; 38: 123-149 		062131
#Date / Author / JournalLCSGCSLCRCR
3316463 Ceballos-Baumann AO, Brooks DJ
Basal ganglia function and dysfunction revealed by PET activation studies
ADVANCES IN NEUROLOGY, VOLUME 74. 1997; 74: 127-139 		120883
3326464 Leenders KL
PET modifications after surgery for Parkinson's disease
ADVANCES IN NEUROLOGY, VOLUME 74. 1997; 74: 271-279 		00519
3339500 Stoessl AJ, Lee CS, de la Fuente-Fernandez R
New concepts and tools in imaging for the study of neurodegenerative disease
ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 157-166 		00964
3349501 Bosboom JLW, Stoffers D, Wolters EC
The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease
ADVANCES IN RESEARCH ON NEURODEGENERATION. 2003; 10: 185-195 		13462
33511399 Cerci SS, Tamam Y, Kaya H, Yildiz M, Arslan S
Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease
ADVANCES IN THERAPY. 2007 MAY-JUN; 24 (3): 611-621 		00924
3367509 Drevets WC
Prefrontal cortical-amygdalar metabolism in major depression
ADVANCING FROM THE VENTRAL STRIATUM TO THE EXTENDED AMYGDALA. 1999; 877: 614-637 		926815137
3376512 Voytko ML
Functional and neurobiological similarities of aging in monkeys and humans
AGE. 1997 JAN; 20 (1): 29-44 		11012185
33810713 Lu BW
Understanding and treating neurodegeneration: insights from the flies
AGE. 2005 SEP; 27 (3): 225-239 		005128
3392874 WILCOCK GK
RECENT RESEARCH INTO DEMENTIA
AGE AND AGEING. 1988 MAR; 17 (2): 73-86 		05450
3404469 BURNS A, TYRRELL P
ASSOCIATION OF AGE WITH REGIONAL CEREBRAL OXYGEN UTILIZATION - A POSITRON EMISSION TOMOGRAPHY STUDY
AGE AND AGEING. 1992 SEP; 21 (5): 316-320 		5101131
#Date / Author / JournalLCSGCSLCRCR
3419047 Geerts H, Finkel L, Carr R, Spiros A
Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy
AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS. 2002; : 203-216 		01233
3429502 Trollor JN, Sachdev PS
Ageing of the human brain as studied by functional neuroimaging
AGEING BRAIN. 2003; : 97-138 		013097
3439503 Srikanth VK, Donnan GA
Cerebrovascular system and the ageing brain
AGEING BRAIN. 2003; : 153-169 		002799
3449504 Kwok JBJ, Schofield PR
The molecular basis of Alzheimer's disease and frontotemporal dementia
AGEING BRAIN. 2003; : 173-185 		00548
3459505 Small GW
Detecting Alzheimer's disease at the pre-symptomatic stages
AGEING BRAIN. 2003; : 259-273 		001259
34610219 Schipper HM
Brain iron deposition and the free radical-mitochondrial theory of ageing
AGEING RESEARCH REVIEWS. 2004 JUL; 3 (3): 265-301 		0652128
34710316 Grant MD, Brody JA
Musical experience and dementia. Hypothesis
AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2004 OCT; 16 (5): 403-405 		08123
3485072 MEIERRUGE W, IWANGOFF P, BERTONIFREDDARI C
WHAT IS PRIMARY AND WHAT SECONDARY FOR AMYLOID DEPOSITION IN ALZHEIMERS-DISEASE
AGING CLOCK. 1994; 719: 230-237 		315468
3498494 Newman MC, Holland AL, Caselli RJ, Gongoll R, White K, et al.
Talkativeness in cognitively normal women at genetic risk for Alzheimer's disease
AGING NEUROPSYCHOLOGY AND COGNITION. 2000 DEC; 7 (4): 217-226 		02546
3502924 NAKAJIMA T, HORI H, OHRUI H, MEGURO H, IDO T
SYNTHESIS OF N-ACETYL-3-FLUORO-NEURAMINIC ACIDS
AGRICULTURAL AND BIOLOGICAL CHEMISTRY. 1988 MAY; 52 (5): 1209-1215 		117432
#Date / Author / JournalLCSGCSLCRCR
3511757 KREITEN K, BIERSACK HJ, FROSCHER W, PENIN H, BULAU P, et al.
1ST RESULTS WITH SINGLE-PHOTON-EMISSION COMPUTED-TOMOGRAPHY (SPECT) OF THE BRAIN IN EPILEPTIC PATIENTS
AKTUELLE NEUROLOGIE. 1985; 12 (1): 8-12 		34717
3524967 SEITZ RJ
POSITRON EMISSION TOMOGRAPHY IN NEUROLOGY - FUNDAMENTALS - QUESTIONS - INDICATIONS
AKTUELLE NEUROLOGIE. 1993 OCT; 20 (5): 177-183 		242463
3539124 Bartenstein P
Receptor imaging with positron emission tomography
AKTUELLE NEUROLOGIE. 2002 FEB; 29 (1): 1-11 		03532109
35412416 Saft C, Kosinski CM, Landwehrmeyer GB
Progress in Premanifest and Manifest Diagnostics in Huntington's Disease
AKTUELLE NEUROLOGIE. 2009 DEC; 36 (10): 506-+ 		1134250
3551188 HART JR
POSITRON EMISSION TOMOGRAPHY - APPLICATION TO NEUROLOGY
ALABAMA JOURNAL OF MEDICAL SCIENCES. 1983; 20 (2): 174-175 		0038
3569733 Bilgi C, Tokgoz S, Aydin A, Celik T, Uzbay IT
The effects of chronic ethanol consumption and ethanol withdrawal on serum cholinesterase activity in rats
ALCOHOL AND ALCOHOLISM. 2003 JUL-AUG; 38 (4): 316-320 		03128
3572297 JOHNSON JL, ADINOFF B, BISSERBE JC, MARTIN PR, RIO D, et al.
ASSESSMENT OF ALCOHOLISM-RELATED ORGANIC BRAIN SYNDROMES WITH POSITRON EMISSION TOMOGRAPHY
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1986 JUN; 10 (3): 237-240 		16848
3583604 DEWIT H, METZ J, WAGNER N, COOPER M
BEHAVIORAL AND SUBJECTIVE EFFECTS OF ETHANOL - RELATIONSHIP TO CEREBRAL METABOLISM USING PET
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1990 JUN; 14 (3): 482-489 		854421
3595027 SCHWARTZ JA, SPEED NM, GROSS MD, LUCEY MR, BAZAKIS AM, et al.
ACUTE EFFECTS OF ALCOHOL ADMINISTRATION ON REGIONAL CEREBRAL BLOOD-FLOW - THE ROLE OF ACETATE
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1993 DEC; 17 (6): 1119-1123 		117529
3606177 Leong DK, Oliva L, Butterworth RF
Quantitative autoradiography using selective radioligands for central and peripheral-type benzodiazepine receptors in experimental Wernicke's encephalopathy: Implications for positron emission tomography imaging
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1996 MAY; 20 (3): 601-605 		36432
#Date / Author / JournalLCSGCSLCRCR
3616398 Gilman S, Adams KM, JohnsonGreene D, Koeppe RA, Junck L, et al.
Effects of disulfiram on positron emission tomography and neuropsychological studies in severe chronic alcoholism
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1996 NOV; 20 (8): 1456-1461 		18968
3627068 Adams KM, Gilman S, Johnson-Greene D, Koeppe RA, Junck L, et al.
The significance of family history status in relation to neuropsychological test performance and cerebral glucose metabolism studied with positron emission tomography in older alcoholic patients
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1998 FEB; 22 (1): 105-110 		013643
3638025 Noto D, Takeda T, Wu J, Lwin TT, Yu Q, et al.
Development of a multispectral autoradiography using a coded apesture
ALGORITHMS AND SYSTEMS FOR OPTICAL INFORMATION PROCESSING IV. 2000; 4113: 123-133 		00210
3643790 SALETU B, ANDERER P, PAULUS E, GRUNBERGER J, WICKE L, et al.
EEG BRAIN MAPPING IN DIAGNOSTIC AND THERAPEUTIC ASSESSMENT OF DEMENTIA
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1991; 5: S57-S75 		222640
3654028 BROWN WD, FRACKOWIAK RSJ
CEREBRAL BLOOD-FLOW AND METABOLISM STUDIES IN MULTIINFARCT DEMENTIA
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1991 SUM; 5 (2): 131-143 		5202172
3665512 RASKIND MA, CARTA A, BRAVI D
IS EARLY-ONSET ALZHEIMER-DISEASE A DISTINCT SUBGROUP WITHIN THE ALZHEIMER-DISEASE POPULATION
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1995; 9: S2-S6 		114440
3675649 HERHOLZ K
FDG PET AND DIFFERENTIAL-DIAGNOSIS OF DEMENTIA
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1995 SPR; 9 (1): 6-16 		558892148
3686011 Minthon L, Edvinsson L, Gustafson L
Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 WIN; 10 (4): 197-203 		416343
3696366 Labbe C, Froment JC, Kennedy A, Ashburner J, Cinotti L
Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1996 FAL; 10 (3): 141-170 		346649123
3706721 Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Jonker C
The diagnostic value of magnetic resonance imaging and technetium 99m HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997 JUN; 11 (2): 63-70 		638950
#Date / Author / JournalLCSGCSLCRCR
3716839 Nakamura T, Meguro K, Yamazaki H, Okuzumi H, Tanaka A, et al.
Postural and gait disturbance correlated with decreased frontal cerebral blood flow in Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1997 SEP; 11 (3): 132-139 		028450
3727349 Gainotti G, Marra C, Villa G, Parlato V, Chiaretti F
Sensitivity and specificity of some neuropsychological markers of Alzheimer dementia
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 SEP; 12 (3): 152-162 		641354
3737350 Fujimori M, Imamura T, Yamashita H, Hirono N, Ikejiri Y, et al.
Age at onset and visuocognitive disturbances in Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 SEP; 12 (3): 163-166 		519430
3747465 Hirono N, Mori E, Yasuda M, Ishii K, Ikejiri Y, et al.
Lack of association of apolipoprotein E epsilon 4 allele dose with cerebral glucose metabolism in Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 DEC; 12 (4): 362-367 		1932526
3757466 Kurz A, Riemenschneider S, Buch K, Willoch F, Bartenstein P, et al.
Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 1998 DEC; 12 (4): 372-377 		342330
3768026 Jelic V, Nordberg A
Early diagnosis of Alzheimer disease with positron emission tomography
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000; 14: S109-S113 		9202859
3778027 Shinotoh H, Namba H, Fukushi K, Nagatsuka S, Tanaka N, et al.
Brain acetylcholinesterase activity in Alzheimer disease measured by positron emission tomography
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000; 14: S114-S118 		710715
3788204 Stoppe G, Bruhn H, Pouwels PJW, Hanicke W, Frahm J
Alzheimer disease: Absolute quantification of cerebral metabolites in vivo using localized proton magnetic resonance spectroscopy
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2000 APR-JUN; 14 (2): 112-119 		112654
3799096 Grunwald M, Busse F, Hensel A, Riedel-Heller S, Kruggel F, et al.
Theta-power differences in patients with mild cognitive impairment under rest condition and during haptic tasks
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 JAN-MAR; 16 (1): 40-48 		217540
3809387 Collette F, Van der Linden M, Delrue G, Salmon E
Frontal hypometabolism does not explain inhibitory dysfunction in Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2002 OCT-DEC; 16 (4): 228-238 		518555
#Date / Author / JournalLCSGCSLCRCR
3819734 DeKosky S
Early intervention is key to successful management of Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17: S99-S104 		222661
3829735 Atiya M, Hyman BT, Albert MS, Killiany R
Structural magnetic resonance imaging in established and prodromal Alzheimer disease: A review
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 JUL-SEP; 17 (3): 177-195 		2239153
38310739 Akwa Y, Allain HV, Bentue-Ferrer D, Berr C, Bordet N, et al.
Neuroprotection and neurodegenerative diseases - From biology to clinical practice
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2005 OCT-DEC; 19 (4): 226-239 		084143
38410879 Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, et al.
The role of biomarkers in clinical trials for Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 JAN-MAR; 20 (1): 6-15 		10701095
38510960 Nordberg A
Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2006 APR-JUN; 20 (2): S12-S18 		134549
38611368 Choo IH, Lee DY, Youn JC, Jhoo JH, Kim KW, et al.
Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 APR-JUN; 21 (2): 77-84 		572147
38711573 Kertesz A
Pick complex - Historical introduction
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S5-S7 		00640
38811902 Olson BLB, Holshouser BA, Britt W, Mueller C, Baqai W, et al.
Longitudinal metabolic and cognitive changes in mild cognitive impairment patients
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JUL-SEP; 22 (3): 269-277 		05937
38911903 Rudzinski LA, Fletcher RM, Dickson DW, Crook R, Hutton ML, et al.
Early onset familial Alzheimer disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2008 JUL-SEP; 22 (3): 299-307 		23339
39012485 Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, et al.
ASL Perfusion MRI Predicts Cognitive Decline and Conversion From MCI to Dementia
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 JAN-MAR; 24 (1): 19-27 		001366
#Date / Author / JournalLCSGCSLCRCR
39112486 Pihlajamaki M, O'Keefe K, Bertram L, Tanzi RE, Dickerson BC, et al.
Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease
ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2010 JAN-MAR; 24 (1): 28-36 		011555
3928539 Nordberg A, Jelic V, Arnaiz E, Langstrom B, Almkvist O
Brain functional imaging in early and preclinical Alzheimer's disease
ALZHEIMER'S DISEASE. 2001; : 153-164 		341844
3938540 Small GW, Ercoli LM, Silverman DHS, Huang SC, Bookheimer SY, et al.
Influence of apoE genotype and PET brain imaging on preclinical prediction of Alzheimer's disease
ALZHEIMER'S DISEASE. 2001; : 193-203 		01829
3948541 Mufson EJ, Gilmor M, Ma SY, Levey AI, Kordower JH
Phenotypic differences in cholinergic markers within the nucleus basalis in individuals with mild cognitive impairment
ALZHEIMER'S DISEASE. 2001; : 253-264 		00222
3957510 Lantos PL
Cracking an enigma: The puzzle of unusual dementias
ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 509-522 		02652
3969048 Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, et al.
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-Like pathology in aged transgenic mice
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 45-64 		241698
3979049 Kondo M, Imahori Y, Mori S, Nakajima K
Inositol phospholipid metabolism in Alzheimer's disease - A positron emission tomographic study
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 416-422 		00416
3989050 Watanabe T, Akiguchi I, Yagi H, Onishi K, Kawasaki T, et al.
Proton magnetic resonance spectroscopy and white matter hyperintensities on magnetic resonance imaging in patients with Alzheimer's disease
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 423-429 		18110
3999051 Mori S
Responses to donepezil in Alzheimer's disease and Parkinson's disease
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY. 2002; 977: 493-500 		11418
40011721 Foster NL, Wanga AY, Tasdizen T, Fletcher PT, Hoffman JM, et al.
Realizing the potential of positron emission tomography with F-18- fluorodeoxyglucose to improve the treatment of Alzheimer's disease
ALZHEIMERS & DEMENTIA. 2008 JAN; 4 (1): S29-S36 		672646
Page 4 of 129: [  1  2  3  4  5  6  7  8  9  10 ]  11   21   31   41   51   61   71   81   91  |  101